Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

ALK-Negative Anaplastic Large Cell Lymphoma (ALCL): Prognostic Implications of Molecular Subtyping and JAK-STAT Pathway.

Applied immunohistochemistry & molecular morphology : AIMM - 1 Oct 2021

Parkhi Mayur, Bal Amanjit, Das Ashim, Kashyap Dharambir, Bhardwaj Sandeep, Prakash Gaurav, Malhotra Pankaj

Abstract excerpt

The anaplastic lymphoma kinase (ALK)-negative anaplastic large cell lymphoma (ALCL) is a clinically distinct but heterogeneous entity and lacks the specific immunophenotypic or genetic features compared with the ALK-positive ALCL. Recent molecular studies have provided genetic landscapes of ALK-negative ALCL that have prognostic significance. In this study, we subtyped ALK-negative ALCL based on DUSP22...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Disease-Free Survival
Share to Gene Expression Regulation, Neoplastic

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Janus Kinases

Share to Lymphoma, Large-Cell, Anaplastic

Share to Mutation

Share to Neoplasm Proteins

Share to STAT3 Transcription Factor

Share to Survival Rate

Source

Identifiers

PMID: 33901030
DOI: 10.1097/PAI.0000000000000936

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

ALK-Negative Anaplastic Large Cell Lymphoma (ALCL): Prognostic Implications of Molecular Subtyping and JAK-STAT Pathway.PMID 33901030Read ↗

ALK-negative anaplastic large cell lymphoma is a genetically heterogeneous disease with widely disparate clinical outcomesSemantic proximity Read ↗

Anaplastic Large Cell LymphomasSemantic proximity Read ↗

ALCL by any other name: the many facets of anaplastic large cell lymphoma.Semantic proximity Read ↗

Anaplastic large cell lymphoma: pathology, genetics, and clinical aspects.Semantic proximity Read ↗

Updates in pathobiological aspects of anaplastic large cell lymphomaSemantic proximity Read ↗

Genetics of anaplastic large cell lymphoma.Semantic proximity Read ↗

Molecular Screening in Anaplastic Lymphoma Kinase–Positive Anaplastic Large Cell Lymphoma: Anaplastic Lymphoma Kinase Analysis, Next-Generation Sequencing Fusion Gene Detection, and T-Cell Receptor ImmunoprofilingSemantic proximity Read ↗

ALK-positive anaplastic large cell lymphoma an evolving storySemantic proximity Read ↗

Morphologic Features of ALK-negative Anaplastic Large Cell Lymphomas With DUSP22 Rearrangements.Semantic proximity Read ↗

Translocations involving anaplastic lymphoma kinase (ALK).Semantic proximity Read ↗

Anaplastic Lymphoma Kinase (ALK) Receptor Tyrosine Kinase: A Catalytic Receptor with Many FacesSemantic proximity Read ↗

DUSP22 and TP63 rearrangements predict outcome of ALK-negative anaplastic large cell lymphoma: a Danish cohort studySemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.